While GlaxoSmithKline recently decided to stop paying doctors to advocate its drugs, it's possible that drug groups could be tempted to reproduce those murky practices in vulnerable emerging markets.
John Gapper
Advertisement
Articles by John Gapper
Advertisement
Latest Updated Articles
Doctors are Meant to Prescribe, Not to PromotePublished: December 20th 2013 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
Remote monitoring boosts Medicare revenue by 20% for primary care practices, study finds
2
2026 Medicare Physician Fee Schedule: Payment up 2.5% as CMS shifts from ‘sick-care’ to health care
3
2026 Medicare Physician Fee Schedule: Some benefits for accountable care, telehealth
4
The 10 places hit hardest by the government shutdown
5
